The global specialty generics market reached a value of US$ 44.8 Billion in 2018. Looking forward, the market value is further expected to reach US$ 88.9 Billion by 2024, exhibiting a CAGR of 11.9% during 2019-2024.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them.

The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

This latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global smart lighting market in any manner.

Key Questions Answered

  • How has the global specialty generics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global specialty generics industry?
  • What is the breakup of the global specialty generics market based on the indication?
  • What is the breakup of the global specialty generics market based on the route of administration?
  • What is the breakup of the global specialty generics market based on the distribution channel?
  • \What are the various stages in the value chain of the global specialty generics industry?
  • What are the key driving factors and challenges in the global specialty generics market?
  • What is the structure of the global specialty generics industry and who are the key players?
  • What is the degree of competition in the global specialty generics market?

Key Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

6.1 Market Overview

6.2 Market Performance

6.3 Market Breakup by Route of Administration

6.4 Market Breakup by Indication

6.5 Market Breakup by Distribution Channel

6.6 Market Breakup by Region

6.7 Market Forecast

6.8 SWOT Analysis

6.9 Value Chain Analysis

6.10 Porters Five Forces Analysis

6.11 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration

7.1 Injectable

7.2 Oral

7.3 Others

8 Market Breakup by Indication

8.1 Oncology

8.2 Autoimmune Diseases

8.3 Infectious Diseases

8.4 Others

9 Market Breakup by Distribution Channel

9.1 Retail Pharmacies

9.2 Specialty Pharmacies

9.3 Hospital Pharmacies

10 Market Breakup by Region

10.1 North America

10.2 Europe

10.3 Asia Pacific

10.4 Latin America

10.5 Middle East and Africa

11 Competitive Landscape

11.1 Market Structure

11.2 Key Players

11.3 Profiles of Key Players

11.3.1 Teva Pharmaceuticals Industries

11.3.2 Akorn Inc.

11.3.3 Mylan N.V.

11.3.4 Mallinckrodt

11.3.5 Sandoz International GmbH

11.3.6 Pfizer Inc.

11.3.7 Sun Pharmaceutical Industries Ltd.

11.3.8 Valeant Pharmaceuticals

11.3.9 Apotex Corp.

11.3.10 Endo International PLC

For more information about this report visit https://www.researchandmarkets.com/r/kp9y17

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Generic Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/15/2019 06:38 AM/DISC: 04/15/2019 06:38 AM

Copyright Business Wire 2019.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.